Zogenix (ZGNX) is one of the pharma’s biggest losers today. The reason?
With primary care clinicians playing an ever-increasing role in the management of diabetes, staying on top of new developments in the American Diabetes …
Do you have high cholesterol? Investors in Amarin (AMRN) kind of hope that you do — but ideally, not too high.
It’s a short and dramatic plunge for Biogen (BIIB) stock. Today, the biotech giant’s shares lost 29% of their value and reached levels …
It’s a very rewarding trading day for investors in Spark Therapeutics (ONCE) with shares skyrocketing 120%, making the stock Wall Street’s bull of …
Bausch Health (BHC) saw its shares crater by as much as 10% today on exceptionally high volume. This drop was triggered by the release …
You know there was some bad news with a company’s quarterly update when the stock tanks after the results are announced. That’s what …
With Intercept (ICPT) preparing to release Phase 3 results from its REGENERATE study in Non-Alcoholic Steatohepatitis (NASH) patients, Gilead (GILD) announced yesterday that its top late-stage NASH drug …
It’s a very rewarding trading day for investors in MacroGenics (MGNX) with shares up over 120%, making the stock Wall Street’s bull of …
Shares of Trevena (TRVN) came back to life. The struggling biotech stock took a rare leap upward last week, as well as today, as resolution …
